-
Abstract Number: PB2436
Saddle Pulmonary Embolism in the Era of Incidental Events: Incidence, Clinical Findings and Outcomes in a Single Center Cohort
-
Abstract Number: PB2318
Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes
-
Abstract Number: PB0923
Safety and Efficacy of Albutrepenonacog Alfa ih Haemophilia Patients: The Greek Experience
-
Abstract Number: OC 12.2
Safety and Efficacy of Anticoagulant Therapy in Pediatric Catheter-related Venous Thrombosis (EINSTEIN-Jr. CVC-VTE): A Pre-specified Substudy
-
Abstract Number: PB0960
Safety and Efficacy of FVIII Replacement with Turoctocog Alfa in the UK
-
Abstract Number: PB1211
Safety of Antithrombotic Therapy in Subjects with Hereditary Hemorrhagic Telangiectasia
-
Abstract Number: PB2281
Safety of Using the Wells Rule and D-Dimer Test for Excluding Acute Recurrent Ipsilateral Deep Vein Thrombosis
-
Abstract Number: PB2514
Safety of Withholding Antithrombotic Treatment in Pregnancies after Antiphospholipid Antibodies Disappearance in Women with Obstetric Antiphospholipid Syndrome, a Cohort Study
-
Abstract Number: PB0545
Sample Stability for a Broad Panel of Coagulation Assays on the Cobas t 711 Analyser Using Plasma Stored under Different Conditions
-
Abstract Number: PB1834
Sarcoidosis and Autoimmune Thrombocytopenic Purpura: Random Association or Hematologic Manifestation of Sarcoidosis?
-
Abstract Number: PB1057
Satisfaction and Preference of Hemophilia A Patients and Parents for the Treatments in Korea; Results from a Multicentered, Cross-sectional, Observational Study
-
Abstract Number: PB0334
Screening of Hematuria in Children with Hemophilia: A Preliminary Report
-
Abstract Number: PB0924
Screening of Inhibitor Development among Haemophilia a Patients Being Treated with Recombinant Factor VIII Concentrates in South-East Nigeria
-
Abstract Number: PB2337
Seasonality in Hospitalizations for Pulmonary Embolism between 2006 – 2016
-
Abstract Number: PB0958
Second Interim Analysis Results from the STASEY Trial: A Single-Arm, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Safety and Tolerability of Emicizumab Prophylaxis in People with Hemophilia A (PwHA) with FVIII Inhibitors
-
Abstract Number: PB0099
Secondary Brain Damage in Mouse Models of Focal and Global Ischaemia and Haemorrhagic Stroke: A Comparative Study
-
Abstract Number: PB1241
Secondary Immune Thrombocytopenia in Children: Characteristics and Outcome of a Large Cohort from Two Spanish Centers
-
Abstract Number: PB1915
Secondary Thromboprophylaxis in Antiphospholipid Syndrome Patients with Arterial Thrombosis: A Systematic Review and Meta-analysis
-
Abstract Number: PB0810
Seeking New Approaches: Aberrant Clots, Fibrin Degradation Products and their Effects on Clot Stability
-
Abstract Number: PB1465
Selatogrel, a Potent P2Y12 Receptor Antagonist, Dissolves Pre-Formed Platelet-thrombi in vivo
-
Abstract Number: PB0032
Selective Targeting of Shear Gradient Activated Von Willebrand Factor by the Novel Single-Chain Antibody Scfv-A1 Reduces Occlusive Thrombus Formation
-
Abstract Number: PB0809
Self-Adjustment of Prescribed Dosing Regimens and Physical Activity by Persons with Hemophilia (PwH): Findings from the HemACTIVE Patient Survey
-
Abstract Number: PB1268
Self-Management of Oral Anticoagulation with Vitamin K Antagonist Programs Progressively Improves Time in Therapeutic Range in Pediatric Population
-
Abstract Number: PB1648
Septins Contribute to Platelet Shape and Functionality
-
Abstract Number: PB0237
Sequence Mismatch Between Therapeutic (t) and Endogenous (e) Factor VIII Proteins (FVIIIs), and HLA-class-II (HLAcII)-binding in the Development of Neutralizing Anti-tFVIII-Antibodies in Hemophilia A (HA): Evidence from the PATH Study
-
Abstract Number: PB2262
Serial Ultrasounds in Deep Vein Thrombosis Diagnosis, a Single Centre Retrospective Review
-
Abstract Number: PB1207
Severe Factor V Deficiency Caused by Two Novel Pathological F5 Variants – First Insights into their Effect on Factor V Function
-
Abstract Number: PB0505
Severe Haemophilia A Plasma Artificially Spiked with Emicizumab and Recombinant Factor VIII Concentrates: Measurement by One-Stage and Chromogenic Factor VIII Assays
-
Abstract Number: PB1477
Severe Platelet Dysfunction in Patient with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) after Tyrosine Kinase Inhibitor (TKI) Therapy
-
Abstract Number: PB1586
Severe Thrombocytopenia after DDAVP Test (DDAVPt) in a Girl with a p.Cys1272Gly Variant of the VWF Gen
-
Abstract Number: OC 07.3
Severity of Acute Events in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) with or without Regular Plasma Prophylaxis: Results from the International Hereditary TTP Registry
-
Abstract Number: PB0140
Sex Bias in Animal Models of Thrombosis Research
-
Abstract Number: PB1715
SHARPIN Restrains αIIbβ3 Activation in Platelets in Three Dimensions
-
Abstract Number: PB1611
Short-term Application of Caffeic Acid Specifically Promotes Expansion of Hematopoietic Stem Cells
-
Abstract Number: PB1153
SIG-001 for Hemophilia A: Preclinical Safety and Efficacy Studies Conducted in Mice and Non-Human Primates
-
Abstract Number: PB0588
Sigma Metrics Scores for Routine Haemostasis Assays in a Small Laboratory
-
Abstract Number: PB1994
Significance of Macrophage Migration Inhibitory Factor and Toll-Like Receptor 4as Predictive Factors of Sepsis in Shock Patients
-
Abstract Number: PB1995
Significance of Macrophage Migration Inhibitory Factor for Sepsis in Hemorrhagic Shock Patients
-
Abstract Number: PB0087
Silent Brain Ischemia in Thalassemia Patients: Breaking the Silence
-
Abstract Number: PB0418
Simulation of TF-dependent Factor X Activation on Phospholipid Vesicles: The Role and Importance of Individual Reaction Stages
-
Abstract Number: PB0358
Simvastatin Prevents Liver and Kidney Microthrombosis After Exposure to Lipopolysaccharide by Preserving the Antithrombotic Properties of the Endothelium
-
Abstract Number: PB1233
Single Center Analysis of the Phenotype of Children Immune Thrombocytopenia with Mutation Related to Common Variable Immunodeficiency
-
Abstract Number: PB2076
Single Centre Daily Practice Evaluation of Bleeding and Thromboembolic Complications in Cancer Patients with Atrial Fibrillation
-
Abstract Number: PB2444
Single Centre Experience of DOAC Use in Patients with Antiphospholipid Syndrome (APS) with Venous Thromboembolism
-
Abstract Number: PB1184
Single Centre Experience of Rare Bleeding Disorders
-
Abstract Number: PB1830
Sirolimus Is Effective in Autoimmune Lymphoproliferative Syndrome (ALPS)/ALPS-Like Syndrome: Results of a Single Centre Experience
-
Abstract Number: PB0488
Six Years of Experience with Plasma Fractionation Industries at a Private Super Speciality Hospital in South India: Renaissance in Usage of Excess Plasma in Blood Banks
-
Abstract Number: PB0808
Small RNAs Influence the Pathophysiology of Hemophilic Synovitis and Arthropathy
-
Abstract Number: PB0121
Small-Molecule Factor XIa Inhibitor, BMS-986177/JNJ-70033093, Prevents and Treats Arterial Thrombosis in Rabbits at Doses that Preserve Hemostasis
-
Abstract Number: PB0022
Smoking Status as Risk Factor and Risk Factors in Young and Elderly Patients Suffered from Myocardial Infarction
-
Abstract Number: PB1972
Snake Venom Cysteine-Rich Secretory Proteins (SVCRISPS) from North American Vipers: Mechanism of Action on Blood and Lymphatic Endothelial Cells
-
Abstract Number: PB1218
Socio-Demographic Data and some Haematological Parameters of Nigerian Children Living on the Street: A Comparative Study
-
Abstract Number: PB2417
Sodium Valproate-induced Drug Interactions with DOAC Anticoagulant Activity: A Case Report
-
Abstract Number: PB0430
Soluble Glycoprotein VI is an Independent Predictor of Major Bleeding in Patients with Suspected Heparin-Induced Thrombocytopenia
-
Abstract Number: PB2017
Specialized Regulatory T Cells Control Venous Blood Clot Resolution
-
Abstract Number: PB1841
Specific Inhibition of MRP4 Affects Several Signaling Pathways and Thrombus Formation in Human Platelets
-
Abstract Number: PB2021
Stabilin-2 Promoter Modulates Immune Response in the Liver of Lentiviral Vector Injected Mice
-
Abstract Number: PB1353
Stability of Crushed Avatrombopag Tablets Demonstrated in Multiple Food Vehicles
-
Abstract Number: PB2039
Standard Versus Higher Intensity Anticoagulation for Patients with Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism: A Multi-center Registry Analysis
-
Abstract Number: PB0441
Standardization of a Flow Cytometry Platelet Sialylation Assay, and reference Values for Beta-Galactose Exposure in Healthy Subjects
-
Abstract Number: PB0363
State of the Hemostatic System in Diffuse Congenital Arteriovenous Malformations of the Extremities
-
Abstract Number: PB1505
Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene as a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)
-
Abstract Number: PB2077
Stroke, Major Bleeding, and Net-clinical Benefit of Anticoagulation in Patients with Atrial Fibrillation on Hemodialysis
-
Abstract Number: PB1523
Structural Analysis of the VWF molecule with Compound in Cis Heterozygous p.R924Q and p.A2178S Mutations Causing a Type 2B-Like von Willebrand Disease
-
Abstract Number: PB2197
Structural Basis of the Pro-coagulant Phenotype of Prothrombin Variant Arg553Trp (p.Arg596Trp – Padua 2)
-
Abstract Number: PB0253
Structure-Function Relationships in Factor XII Studied with Factor XII-HGFA Chimeras
-
Abstract Number: PB0183
Structures in the Presence and Absence of an Anti-Factor VIII C1 Domain Antibody Bound to a Bioengineered Factor VIII Construct Indicates Multiple C2 Domain Conformations
-
Abstract Number: PB0412
Study of a New Synthetic Thrombin Inhibitor IEM-2280
-
Abstract Number: PB0057
Study of Fluctuations in the Endothelin Concentration of the Crew Trans-Latitude Journey Transarctica-2019
-
Abstract Number: PB2209
Study of Plasma miRNAs and Microparticle miRNAs in Severe Forms of Pulmonary Hypertension
-
Abstract Number: PB2078
Study of Real Clinical Practice to Evaluate the Efficacy and Safety of Edoxaban in Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation. Differences between Results by Age and Creatinine Clearance Greater than 95 ml/min
-
Abstract Number: PB0069
Study of the Endothelial Dysfuncion in Patients with Cancer: Preliminary Results
-
Abstract Number: PB0484
Study of the Stability of the Main Parameters of Hemostasis Over Six Hours
-
Abstract Number: PB2504
Study of the State of the Hemostatic System in Women with Various Pregnancy Complications
-
Abstract Number: PB0058
Study of Thrombine Generation Assay Parameters of the Crew Trans-Latitude Journey Transartika-2019
-
Abstract Number: PB1014
Subclinical deep venous thrombosis identified in 7,5% of people with hemophilia undergoing major orthopedic surgery in the absence of pharmacological thromboprophylaxis
-
Abstract Number: PB1227
Successful Development and Implementation of Pharmacist-led VTE Stewardship. An Australian Tertiary Hospital Perspective
-
Abstract Number: PB1791
Successful Improvement Sexual Dysfunction After Pelvic Irradiation by Platelet Growth Factor
-
Abstract Number: PB1077
Successful Inhibitor Eradication for Hemophilia A Children with Poor-risk High-titer Inhibitor Using Low-dose Immune Tolerance Induction Strategy
-
Abstract Number: PB0881
Successful Multiple Surgeries in Adult Patients with Haemophilia A (HA) Treated With Turoctocog Alfa Pegol (N8-GP) in the Pathfinder 3 trial
-
Abstract Number: PB0984
Successful Parotid Tumor Surgery in Hemophilia a Patient after Immune Tolerance Induction (ITI) with High-Purity Human FVIII/ von Willebrand Factor (vWF)
-
Abstract Number: PB1484
Successful Perioperative Hemostasis for Glyoblastoma Surgery in a Patient with Glanzmann Thrombasthenia
-
Abstract Number: PB2565
Successful Pregnancy Outcomes in Patients with Protein S Deficiency Treated with Daily Fondaparinux Regimen
-
Abstract Number: PB1573
Successful Surgical Interventions In Children with von Willebrand Disease Type 3
-
Abstract Number: PB0794
Successful Treatment of a Rare Acquired Thrombin Inhibitor in a Patient with Hemodialysis-dependent End-stage Renal Disease
-
Abstract Number: PB1060
Successful Use of Immunotherapy in the Management of Cancer in Patients with Hemophilia B
-
Abstract Number: PB0186
Suppression of Factor VIII-Specific Memory B Cells by Murine and Human BAR-Tregs
-
Abstract Number: PB1085
Surgery in People with Hemophilia and Inhibitors: 10 Years of Experience in a Portuguese Comprehensive Care Centre
-
Abstract Number: PB0939
Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A (PwHA) with FVIII Inhibitors: Data from the Second Interim Analysis
-
Abstract Number: PB1154
Surgical Experience with Emicizumab: A Single Centre Experience with Central Venous Access Device Removal
-
Abstract Number: PB1096
Surgical Experience with Fidanacogene Elaparvovec
-
Abstract Number: PB1104
Surgical Management of a Hemophilia B Gene Transfer Clinical Trial Participant: A Case Report Following Etranacogene Dezaparvovec (AMT-061) Gene Therapy
-
Abstract Number: PB0986
Surrogate FVIII Activity in Patient and Constructed Plasma Samples Containing Emicizumab: A National External Quality Assurance Scheme for Blood Coagulation (UK NEQAS BC) Exercise
-
Abstract Number: PB2440
Survey on the Prescription and Biological Monitoring of Direct Oral Anticoagulants in Algeria
-
Abstract Number: PB2103
Survival after Cancer-related Venous Thrombosis: The Scandinavian Thrombosis and Cancer Study (STAC)
-
Abstract Number: PB1343
Sustained Remission after Withdrawal of Thrombopoietin Receptor-Agonists in Immune Thrombocytopenia
-
Abstract Number: PB1073
Switch to Extended Half-life Recombinant Single Chain Factor VIII in Haemophilia A Patients. Experience in One Centre
-
Abstract Number: PB1542
Symptomatic Venous Aneurysm of the Internal Jugular Vein Presenting with Small Thrombotic Inclusions in von Willebrand Disease Type I
-
Abstract Number: PB1388
Synthesis of Antiplatelet Ortho-Carbonyl Hydroquinones: A Spiro Derivative is Selective against Collagen-Stimulated Platelets
-
Abstract Number: PB0024
Synthetic Antisense Oligodeoxynucleotides – Loaded Microbubbles – Mediated Transfection Therapy using B-Mode Ultrasound – Guided Focused Shock Waves Decreases Neointimal Hyperplasia Restenosis after Laser Angioplasty of Advanced Atherosclerotic Severe Stenosis
-
Abstract Number: PB0409
System Wide Investigation into Coagulation Profile of Premature Myocardial Infarction Subjects
-
Abstract Number: PB2471
Systematic Review of the Risk of Bleeding in Patients with Chronic Kidney Disease Treated with Tinzaparin
-
Abstract Number: PB2510
Systematic Review of Viscoelastic Testing (TEG/ROTEM) in Obstetrics and Recommendations for Future Studies
-
Abstract Number: PB0075
Systemic Aspirin Esterification in Subjects with Cardiovascular Disease: Impact of Body Size
-
Abstract Number: PB2519
Systemic Evaluation of Neuroserpin, Interleukin-17 and Hemostatic Factors in Association with Clinical Parameters in Preeclamptic Women: A Principal Component Analysis Approach
-
Abstract Number: PB1999
Systemic Inflammation in Sepsis Patients Is Demonstrated by Levels of IL-8, IL-13, and TAFI
-
Abstract Number: PB1598
Systmetic Study of Biological Properties and Functions of Bone Marrow Mesenchymal Stem Cells from Patients with Essential Thrombocythemia and Explore the Effects of Interferonα-2b on Them
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.